Lai to the Academia Sinica (Taiwan). Investigators 
C. Thomas Caskey and Max D. Cooper were elected 
Fellows of the Royal Society of Medicine Founda- 
tion, Inc. 
The Institute's Investigators have continued to 
participate actively in their professional societies 
and to contribute their efforts to the larger scientific 
community. For example, Associate Investigator 
Arthur Weiss served as President of the Western Re- 
gion of the American College of Physicians; Investi- 
gator Charles A. Janeway, Jr., is a councillor of the 
American Association of Immunologists and a 
member of the Board of Directors of FASEB; Asso- 
ciate Investigator Donald E. Ganem serves as a coun- 
cillor of the American Society for Virology; and As- 
sociate Investigator Bruce A. Beutler was President 
of the International Congress on Tumor Necrosis 
Factor and Related Cytokines. HHMI investigators 
serve on advisory boards and reviewing panels for 
such agencies and organizations as the National Insti- 
tutes of Health, the American Heart Association, the 
American Red Cross, the Searle Scholars and the Pew 
Scholars Programs, Jane Coffin Childs Memorial 
Fund, David and Lucile Packard Foundation, and the 
Damon Runyon and Walter Winchell Cancer Re- 
search Fund. Senior Investigator Donald F. Steiner 
served as Chairman of the Board of Scientific Coun- 
selors of the National Institute of Diabetes and Di- 
gestive and Kidney Diseases, NIH; Investigators Uta 
Francke and Charles A. Janeway, Jr., served as chair- 
persons of the Mammalian Genetics and the Immu- 
nobiology Study Sections of NIH, respectively. 
INTERNATIONAL RESEARCH SCHOLARS 
Through grants to their respective institutions, 
the Institute supported research projects in the labo- 
ratories of 10 scientists at 4 institutions in Mexico 
and 14 at 7 institutions in Canada. 
Mexico 
Carlos F. Arias, Ph.D., Biotechnology Institute, 
National Autonomous University of Mexico, 
Cuernavaca 
Edmundo Calva, Ph.D., Biotechnology Institute, 
National Autonomous University of Mexico, 
Cuernavaca 
Gabriel Cota, Ph.D., National Polytechnic 
Institute, Mexico City 
Alberto Darszon, Ph.D., Biotechnology Institute, 
National Autonomous University of Mexico, 
Cuernavaca 
Gabriel Guarneros-Pena, Ph.D., National 
Polytechnic Institute, Mexico City 
Luis R. Herrera-Estrella, Ph.D., National 
Polytechnic Institute, Irapuato 
Paul M. Lizardi, Ph.D., Biotechnology Institute, 
National Autonomous University of Mexico, 
Cuernavaca 
Esther Orozco, Ph.D., National Polytechnic 
Institute, Mexico City 
Lourival D. Possani, Ph.D., Biotechnology 
Institute, National Autonomous University 
of Mexico, Cuernavaca 
Ranulfo Romo, M.D., Ph.D., Institute of Cellular 
Physiology, National Autonomous 
University of Mexico, Mexico City 
Canada 
Alan Bernstein, Ph.D., Samuel Lunenfeld 
Research Institute of Mount Sinai Hospital, 
Toronto, and the University of Toronto 
B. Brett Finlay, Ph.D., University of British 
Columbia, Vancouver 
Jack F. Greenblatt, Ph.D., University of Toronto 
Sergio Grinstein, Ph.D., The Research Institute 
of the Hospital for Sick Children, Toronto, 
and the University of Toronto 
Philippe Gros, Ph.D., McGill University, 
Montreal 
Alexandra L. Joyner, Ph.D., Samuel lunenfeld 
Research Institute of Mount Sinai Hospital, 
Toronto, and the University of Toronto 
James D. McGhee, Ph.D., University of Calgary, 
Alberta 
Tim Mosmann, Ph.D., University of Alberta, 
Edmonton 
Tony Pawson, Ph.D., Samuel lunenfeld 
Research Institute of Mount Sinai Hospital, 
Toronto, and the University of Toronto 
Randy J. Read, Ph.D., University of Alberta, 
Edmonton 
Janet Rossant, Ph.D., Samuel Lunenfeld 
Research Institute of Mount Sinai Hospital, 
Toronto, and the University of Toronto 
Jean-Pierre Roy, M.D., McGill University, 
Montreal 
Terry P. Snutch, Ph.D., University of British 
Columbia, Vancouver 
Lap-Chee Tsui, Ph.D., The Research Institute of 
the Hospital for Sick Children, Toronto, and 
the University of Toronto 
W. Maxwell Cowan, M.D., Ph.D. 
Vice President and Chief Scientific Officer 
xii 
